- Home
- SNAL vs CRIS Comparison
SNAL vs CRIS Comparison
Compare SNAL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAL
- CRIS
- Stock Information
- Founded
- SNAL 2000
- CRIS 2000
- Country
- SNAL United States
- CRIS United States
- Employees
- SNAL N/A
- CRIS N/A
- Industry
- SNAL Computer Software: Prepackaged Software
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNAL Technology
- CRIS Health Care
- Exchange
- SNAL Nasdaq
- CRIS Nasdaq
- Market Cap
- SNAL 27.6M
- CRIS 31.2M
- IPO Year
- SNAL 2022
- CRIS 2000
- Fundamental
- Price
- SNAL $1.26
- CRIS $4.00
- Analyst Decision
- SNAL
- CRIS Strong Buy
- Analyst Count
- SNAL 0
- CRIS 3
- Target Price
- SNAL N/A
- CRIS $23.00
- AVG Volume (30 Days)
- SNAL 96.2K
- CRIS 68.2K
- Earning Date
- SNAL 11-13-2024
- CRIS 11-14-2024
- Dividend Yield
- SNAL N/A
- CRIS N/A
- EPS Growth
- SNAL N/A
- CRIS N/A
- EPS
- SNAL N/A
- CRIS N/A
- Revenue
- SNAL $73,273,736.00
- CRIS $10,161,000.00
- Revenue This Year
- SNAL $48.59
- CRIS N/A
- Revenue Next Year
- SNAL $18.35
- CRIS N/A
- P/E Ratio
- SNAL N/A
- CRIS N/A
- Revenue Growth
- SNAL 35.00
- CRIS N/A
- 52 Week Low
- SNAL $0.52
- CRIS $3.70
- 52 Week High
- SNAL $2.29
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- SNAL 46.50
- CRIS 32.54
- Support Level
- SNAL $1.15
- CRIS $3.70
- Resistance Level
- SNAL $1.82
- CRIS $4.55
- Average True Range (ATR)
- SNAL 0.19
- CRIS 0.42
- MACD
- SNAL -0.06
- CRIS -0.04
- Stochastic Oscillator
- SNAL 34.81
- CRIS 23.70
About SNAL Snail Inc.
Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.